Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement

Korean Journal of Internal Medicine

Volumn 25, Issue 4, 2010, Pages 454-457

  Yoon, Jiyeol ^a   Kim, Sungmin ^a   Lee, Soo Chan ^a   Lim, Hongsub ^a  

^a Himchan Hospital   (South Korea)

Author keywords

Arthroplasty; Epoetin alpha; Ferric oxide; Saccharated

Indexed keywords

ASCORBIC ACID; CYANOCOBALAMIN; DALTEPARIN; FERRIC HYDROXIDE SUCROSE; FOLIC ACID; HEMOGLOBIN; HYDROCORTISONE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; VENOFERUM;

AGED; ANEMIA; ARTICLE; AVASCULAR NECROSIS; CASE REPORT; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DYSPNEA; FEMALE; HIP PAIN; HUMAN; INTRACTABLE PAIN; LOW DRUG DOSE; LUNG FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; THORAX PAIN; THORAX RADIOGRAPHY; TOTAL HIP PROSTHESIS; TREATMENT REFUSAL; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; ANEMIA; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; HUMANS;

EID: 78650972920     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2010.25.4.454     Document Type: Article

References (20)

1. Klein H.G. Allogeneic transfusion risks in the surgical patient. Am J Surg 1995;170(6A Suppl):21S-26S.
2. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003;43:459-469.
3. Cuenca J, García-Erce JA, Martínez F, Pérez-Serrano L, Herrera A, Muñoz M. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006;46:1112-1119.
4. García-Erce JA, Cuenca J, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med 2006;16:335-341.
5. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 2002;84:1299-1304.
6. Atabek U, Alvarez R, Pello MJ, et al. Erythropoetin accelerates hematocrit recovery in post-surgical anemia. Am Surg 1995;61:74-77.
7. Schwenk MH, Blaustein DA. Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease. Clin Nephrol 2004;62:116-120.
8. Aronoff GR, Bennett WM, Blumenthal S, et al. Iron sucrose in Yoon J, et al. Postoperative intravenous iron sucrose with erythropoietin 457 hemodialysis patients: safety of replacement and maintenance regimens. Kidney Int 2004;66:1193-1198.
9. Fletes R, Lazarus JM, Gage J, Chertow GM. Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis 2001;37:743-749.
10. Macdougall IC, Roche A. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections. Am J Kidney Dis 2005;46:283-289.
11. Goodnough LT, Monk TG, Andriole GL. Erythropoietin therapy. N Engl J Med 1997;336:933-938.
12. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-788.
13. Ganz T. Hepcidin: a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005;18:171-182.
14. Brines M, Cerami A. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int 2006;70:246-250.
15. Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007; 357:965-976.
16. Zarychanski R, Turgeon AF, McIntyre L, Fergusson DA. Erythropoietin-receptor agonists in critically ill patients: a meta- analysis of randomized controlled trials. CMAJ 2007;177:725-734.
17. Fliser D, Haller H. Erythropoietin and treatment of non-anemic conditions: cardiovascular protection. Semin Hematol 2007;44:212-217.
18. Sturm B, Laggner H, Ternes N, Goldenberg H, Scheiber-Mojdehkar B. Intravenous iron preparations and ascorbic acid: effects on chelatable and bioavailable iron. Kidney Int 2005;67:1161-1170.
19. Shiga T, Wajima Z, Inoue T, Sakamoto A. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials. Anesth Analg 2005;101:1602-1607.
20. Kourtzis N, Pafilas D, Kasimatis G. Blood saving protocol in elective total knee arthroplasty.Am J Surg 2004;187:261-267.